WntResearch is active in biotechnology. Today the main focus is on the development of drug candidates for various metastatic forms of cancer. The research is focused on studying the bodily-specific protein WNT-5a, which has been found to play a crucial role in the proliferation of tumour cells. The products are licensed to various stakeholders in the industry. The head office is in Malmö.

Quotes for WntResearch AB

Right Now

+/-
%
0,00%
Latest
High
Low
Volume
0
Turnover (SEK)
0
Value (MSEK)
93,0

Board

CEO

  • Anders Rabbe

Chairman Of The Board

  • Gudrun Anstrén

Board

  • Bengt Gustavsson
  • Jan Nilsson
  • Janna Sand-Dejmek
  • Martin Olovsson
  • Peter Ström
  • Tommy Andersson

Videos

Largest Owners

Name Capital % Votes % Date
Avanza Pension 10,47 10,47 2021-06-30
Nordnet Pensionsförsäkring 5,50 5,50 2021-06-30
Linfan Zhang 4,03 4,03 2021-06-30
Gunvald Berger 2,05 2,05 2021-06-30
Kjell Stenberg 1,51 1,51 2021-06-30
Lars-Erik Forsgårdh 1,19 1,19 2021-06-30
Niclas Evertsson 1,03 1,03 2021-06-30
Ali Hyseni 0,95 0,95 2021-06-30
Tommy Andersson 0,82 0,82 2021-06-30
Fredrik Lundgren 0,76 0,76 2021-06-30
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Upcoming reports

  • 2021-08-19 Delårsrapport 2021-Q2

  • 2021-11-18 Delårsrapport 2021-Q3

  • 2022-02-24 Bokslutskommuniké 2021